Carl Dan Scales, MSN, APRN, FNP-C
NPI 1881366011ActiveIndividual· Nurse Practitioner, Primary Care· Plainview, TX
Nurse Practitioner, Primary Care (MSN, APRN, FNP-C) with Methodist Hospital Plainview Texas, practicing in Plainview, Texas. Part D covered 1,735 prescriptions written in 2024, 88% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 6 companies reporting payments in 2025, $177.57 in all, mostly food and beverage. Lists Covenant Hospital Plainview as a hospital affiliation.
Overview
| NPI | 1881366011 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MSN, APRN, FNP-C |
| Sole proprietor | Yes |
| NPI issued | Oct 5, 2021 |
| Last updated in NPPES | Oct 5, 2021 |
| Certified by provider | Oct 5, 2021 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Nurse Practitioner, Primary Care Primary | 363LP2300X | 1056350 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Nurse Practitioner (TX) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 1,735 · 2,806 30-day fills |
|---|---|
| Patients | 277 |
| Total drug cost | $161,245 |
| Generic share | 88% of claims |
Education and affiliations
| Graduation year | 2021 |
|---|---|
| Medicare specialty | Nurse Practitioner |
Medical group
- Methodist Hospital Plainview TexasPlainview, TX · 14 clinicians
Hospital affiliation
- Covenant Hospital PlainviewPlainview, TX
Industry payments (Open Payments)
- 2025$177.57 · 9 payments from 6 companies
- 2024$252.91 · 17 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $56.43 | 2 |
| Novo Nordisk Inc | $43.05 | 2 |
| Abbvie Inc. | $34.25 | 2 |
| Lilly USA, LLC | $15.29 | 1 |
| Bayer Healthcare Pharmaceuticals Inc. | $14.79 | 1 |
What the 2025 payments were for
- Food and Beverage$177.57 · 9 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records